Willing to Pay for Antiviral Treatment of Hepatitis B Patients.
作者信息
Zhang Hua, Huo Mingdong, Chao Jianqian, Liu Pei
机构信息
Dept. of Medical Insurance, School of Public Health, Southeast University, Nanjing, Jiangsu, China.
Zhongda Hospital Affiliated to Southeast University, Nanjing, Jiangsu, China.
出版信息
Iran J Public Health. 2016 Dec;45(12):1660-1661.
Abstract
摘要
相似文献
1
Willing to Pay for Antiviral Treatment of Hepatitis B Patients.
Iran J Public Health. 2016 Dec;45(12):1660-1661.
2
Why We Should Be Willing to Pay for Hepatitis C Treatment.我们为何愿意为丙型肝炎治疗付费。
Clin Gastroenterol Hepatol. 2015 Oct;13(10):1711-3. doi: 10.1016/j.cgh.2015.06.005. Epub 2015 Jun 16.
3
[Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].[中国深圳乙肝相关疾病的经济负担及影响成本的因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1340-5.
4
Patients' willingness to pay for anti-emetic treatment.患者对止吐治疗的支付意愿。
Acta Anaesthesiol Scand. 2007 Jan;51(1):38-43. doi: 10.1111/j.1399-6576.2006.01171.x.
5
How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.公众对用于心血管疾病一级预防的抗高血压药物的支付意愿：中国一城市的调查。
Int J Epidemiol. 2010 Feb;39(1):244-54. doi: 10.1093/ije/dyp213. Epub 2009 Jun 2.
6
Web portals in primary care: an evaluation of patient readiness and willingness to pay for online services.基层医疗中的网络门户：对患者接受程度及为在线服务付费意愿的评估。
J Med Internet Res. 2006 Oct 26;8(4):e26. doi: 10.2196/jmir.8.4.e26.
7
The effect of a hepatitis pay-for-performance program on outcomes of patients undergoing antiviral therapy.肝炎按疗效付费项目对接受抗病毒治疗患者结局的影响。
Eur J Public Health. 2017 Dec 1;27(6):955-960. doi: 10.1093/eurpub/ckx114.
8
How much are patients willing to pay to avoid postoperative muscle pain associated with succinylcholine?患者愿意支付多少钱来避免与琥珀胆碱相关的术后肌肉疼痛？
J Clin Anesth. 2007 Dec;19(8):601-8. doi: 10.1016/j.jclinane.2007.07.005.
9
Caregivers' Willingness to Pay for Technologies to Support Caregiving.照顾者为支持照顾工作的技术支付费用的意愿。
Gerontologist. 2016 Oct;56(5):817-29. doi: 10.1093/geront/gnv033. Epub 2015 Apr 9.
10
Waiting time for cataract surgery and its influence on patient attitudes.白内障手术的等待时间及其对患者态度的影响。
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3636-42. doi: 10.1167/iovs.08-3025. Epub 2009 Jan 10.
本文引用的文献
1
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy.在意大利进行的一项多中心横断面研究中，与慢性乙型肝炎患者获得抗病毒治疗相关的因素。
J Viral Hepat. 2012 Dec;19(12):881-9. doi: 10.1111/j.1365-2893.2012.01615.x. Epub 2012 May 10.
2
Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program.从中国社会保障项目的角度看恩替卡韦治疗对中国慢性乙型肝炎（CHB）患者病毒复制抑制的经济影响。
Value Health. 2008 Mar;11 Suppl 1:S11-22. doi: 10.1111/j.1524-4733.2008.00362.x.
3
Lamivudine for patients with chronic hepatitis B and advanced liver disease.拉米夫定用于慢性乙型肝炎和晚期肝病患者。
N Engl J Med. 2004 Oct 7;351(15):1521-31. doi: 10.1056/NEJMoa033364.
4
Cost sharing in health insurance--a reexamination.医疗保险中的费用分担——重新审视
N Engl J Med. 1995 Apr 27;332(17):1164-8. doi: 10.1056/NEJM199504273321711.
Zotero 插件